| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1044207584 |
| P356 | DOI | 10.1007/S00380-012-0250-9 |
| P698 | PubMed publication ID | 22526379 |
| P2093 | author name string | Hiroshi Yagi | |
| Toshihiko Ishimitsu | |||
| Shigeo Horinaka | |||
| Hideki Yano | |||
| P2860 | cites work | Specific binding to intracellular proteins determines arterial transport properties for rapamycin and paclitaxel | Q35321625 |
| Prevention of restenosis after stenting: the emerging role of inflammation. | Q35877828 | ||
| Inflammation and restenosis after percutaneous coronary interventions | Q35903106 | ||
| Neopterin is associated with plaque inflammation and destabilisation in human coronary atherosclerotic lesions | Q36172876 | ||
| Coronary stenting and inflammation | Q36362982 | ||
| Percutaneous coronary intervention in patients with end-stage renal disease | Q36420216 | ||
| Association between C-reactive protein and angiographic restenosis after bare metal stents: an updated and comprehensive meta-analysis of 2747 patients. | Q37209164 | ||
| The evolving role of inflammatory biomarkers in risk assessment after stent implantation | Q37810669 | ||
| Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial | Q38408984 | ||
| Comparison of inflammatory markers and angiographic outcomes after implantation of sirolimus and paclitaxel-eluting stents | Q38499076 | ||
| Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study | Q40509701 | ||
| Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and incident coronary heart disease: the PRIME Study | Q40564036 | ||
| Sirolimus and paclitaxel provoke different vascular pathological responses after local delivery in a murine model for restenosis on underlying atherosclerotic arteries. | Q41390902 | ||
| Clinical outcomes of sirolimus-eluting stenting after rotational atherectomy | Q43277305 | ||
| Clinical and angiographic outcomes following percutaneous coronary intervention with sirolimus-eluting stents versus bare-metal stents in hemodialysis patients | Q43600517 | ||
| Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization | Q43741707 | ||
| Clinical outcome following percutaneous coronary interventions in patients with chronic renal failure | Q43856223 | ||
| Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? | Q43890118 | ||
| Contribution of stent underexpansion to recurrence after sirolimus-eluting stent implantation for in-stent restenosis | Q44781955 | ||
| Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting, and coronary artery bypass surgery and impact of diabetes | Q44946730 | ||
| Impact of direct sirolimus-eluting stent implantation on the early systemic inflammatory response compared with complementary stent implantation | Q46239203 | ||
| C-reactive protein induces tissue factor expression and promotes smooth muscle and endothelial cell proliferation | Q46603281 | ||
| Effects of drug-eluting stents on systemic inflammatory response in patients with unstable angina pectoris undergoing percutaneous coronary intervention | Q46663848 | ||
| Comparison of effects of drug-eluting stents versus bare metal stents on plasma C-reactive protein levels. | Q46794555 | ||
| Sirolimus-eluting stents vs bare metal stents for coronary intervention in Japanese patients with renal failure on hemodialysis. | Q46833326 | ||
| Inflammatory profile in unstable angina versus stable angina in patients undergoing percutaneous interventions | Q47685534 | ||
| Coronary restenotic reduction of drug-eluting stenting may be due to its anti-inflammatory effects. | Q51005546 | ||
| Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients. | Q51089536 | ||
| Images in cardiovascular medicine. Damage to polymer of a sirolimus-eluting stent. | Q51105020 | ||
| Impact of drug-eluting stents on outcomes of patients with end-stage renal disease undergoing percutaneous coronary revascularization. | Q51136785 | ||
| Impact of coronary culprit lesion calcium in patients undergoing paclitaxel-eluting stent implantation (a TAXUS-IV sub study). | Q51329510 | ||
| Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. | Q64913104 | ||
| Direct proinflammatory effect of C-reactive protein on human endothelial cells | Q73134567 | ||
| Clinical usefulness of drug-eluting stents in the treatment of dialysis patients with coronary artery disease | Q83127261 | ||
| Comparative effects of paclitaxel and rapamycin on smooth muscle migration and survival: role of AKT-dependent signaling | Q83215010 | ||
| Efficacy of paclitaxel-eluting stent implantation in hemodialysis patients | Q83299158 | ||
| P433 | issue | 3 | |
| P921 | main subject | hemodialysis patient | Q126109077 |
| P304 | page(s) | 308-315 | |
| P577 | publication date | 2012-04-22 | |
| P1433 | published in | Heart and Vessels | Q15766690 |
| P1476 | title | Comparison of inflammatory response after implantation of sirolimus- and paclitaxel-eluting stents in patients on hemodialysis | |
| P478 | volume | 28 |
| Q46918588 | Cell adhesion molecules and eNOS expression in aorta of normocholesterolemic mice with different predispositions to atherosclerosis |
| Q44532892 | Influence of hemodialysis duration on mid-term clinical outcomes in hemodialysis patients with coronary artery disease after drug-eluting stent implantation |
| Q40576612 | Nitinol stent implantation for femoropopliteal disease in patients on hemodialysis: results of the 3-year retrospective multicenter APOLLON study |
| Q85965701 | Plasma urokinase antigen and C-reactive protein predict angina recurrence after coronary angioplasty |
| Q51014960 | The late-phase inflammatory response after drug-eluting stent implantation. |
Search more.